Literature DB >> 26816

Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes.

A A Mihas, D J Goldenberg, R L Slaughter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26816     DOI: 10.1001/jama.239.24.2590

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  The three week sulphasalazine syndrome.

Authors:  H Brooks; H G Taylor; F E Nichol
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

Review 2.  Hypersensitivity to 5-ASA suppositories.

Authors:  M L Borum; A Ginsberg
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

3.  Peripheral neuropathy and mesalazine.

Authors:  D K Woodward
Journal:  BMJ       Date:  1989-11-11

Review 4.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

5.  Glandular fever-like illness associated with sulphasalazine.

Authors:  D L Carr-Locke; M Ali
Journal:  Postgrad Med J       Date:  1982-10       Impact factor: 2.401

6.  Acute sulphasalazine hepatotoxicity.

Authors:  P E Jennings; R L Blandford; F D Rosenthal
Journal:  Postgrad Med J       Date:  1986-04       Impact factor: 2.401

7.  Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.

Authors:  Wycliffe S Omwancha; Rama Mallipeddi; Brenda L Valle; Steven H Neau
Journal:  Int J Pharm       Date:  2012-11-28       Impact factor: 5.875

8.  Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Authors:  R S Amos; T Pullar; D E Bax; D Situnayake; H A Capell; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16

9.  Case of relapsing sulfasalazine-induced hypersensitivity syndrome upon re-exposure.

Authors:  Jason Winward; Laurel Lyckholm; Samuel M Brown; Mohamad Mokadem
Journal:  BMJ Case Rep       Date:  2020-09-15

10.  Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.

Authors:  J L Huang; I J Hung; L C Chen; W Y Lee; C Hsueh; K H Hsieh
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.